Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Transfusion Medicine and Hemotherapy is Scopus-indexed (Q2, CiteScore 4.6), WoS SCIE, DOAJ. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 1660-3796Verify ISSN ↗1660-3818Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 48 / 151 | 68th | Q2 |
| Immunology and Allergy | 123 / 234 | 47th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2003–present (also 1975–1997, 1973), best quartile Q2, CiteScore 4.6.
Transfusion Medicine and Hemotherapy is Q2 in Hematology (rank 48 of 151) and Q3 in Immunology and Allergy (rank 123 of 234), by CiteScore 2025.
Transfusion Medicine and Hemotherapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.6, which places it in quartile Q2 at the 68th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.671, quartile Q2, with an H-index of 63.
The publisher lists an article processing charge of about US$1,670 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Transfusion Medicine and Hemotherapy is published by S. Karger AG. Its print ISSN is 1660-3796 and its online ISSN is 1660-3818.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Transfusion Medicine and Hemotherapy has an h-index of 71 and a 2-year mean of 1.81 citations per paper (OpenAlex). Its Scopus CiteScore is 4.6, quartile Q2. On 2-year citations it ranks #57 of 148 Scopus journals in Hematology.
Transfusion Medicine and Hemotherapy published 51 papers in 2025; its busiest recent year was 2019 with 97. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 79 research articles (2024–2026), authors are most often from Germany (53.1%), United States (8.9%) and China (7.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.